Lead by experience, delivered by creativity


Sarfaraz K. Niazi, Ph.D., the founder of Karyo Biologics and Adello Biologics, has achieved many in-practice creative regulatory milestones to reduce the cost/time of development and COGs of biosimilars.

business model

We select, develop and secure FDA approval of biosimilars and license out to commercial sponsors, who have the option of receiving commercial supply or transfer the technology for in-house manufacturing .